Bayesian robustness in meta-analysis for studies with zero responses.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 230, doi. 10.1002/pst.1741
- By:
- Publication type:
- Article
Works matching IS 15391604 AND DT 2016 AND VI 15 AND IP 3
Results: 10
1
2
A win ratio approach to comparing continuous non-normal outcomes in clinical trials.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 238, doi. 10.1002/pst.1743
- By:
- Publication type:
- Article
3
Empirical likelihood based detection procedure for change point in mean residual life functions under random censorship.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 246, doi. 10.1002/pst.1744
- By:
- Publication type:
- Article
4
Decision-making in early clinical drug development.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 255, doi. 10.1002/pst.1746
- By:
- Publication type:
- Article
5
Modelling PK/QT relationships from Phase I dose-escalation trials for drug combinations and developing quantitative risk assessments of clinically relevant QT prolongations.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 264, doi. 10.1002/pst.1747
- By:
- Publication type:
- Article
6
Using Bayesian analysis in repeated preclinical in vivo studies for a more effective use of animals.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 277, doi. 10.1002/pst.1748
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 195, doi. 10.1002/pst.1712
- Publication type:
- Article
8
Predicting analysis time in events-driven clinical trials using accumulating time-to-event surrogate information.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 198, doi. 10.1002/pst.1732
- By:
- Publication type:
- Article
9
Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 208, doi. 10.1002/pst.1737
- By:
- Publication type:
- Article
10
Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints.
- Published in:
- Pharmaceutical Statistics, 2016, v. 15, n. 3, p. 216, doi. 10.1002/pst.1738
- By:
- Publication type:
- Article